IDO1 and cancer: IDO-1 down-regulation by microbiota-derived butyrate in IECs, as demonstrated here, could be crucial for the fine-tuning of IDO-1 expression in healthy conditions and for the initiation of appropriate immune responses depending on the context: chronic inflammation, cancer, obesity or infections.